Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 1
2013 3
2015 1
2016 3
2018 2
2019 2
2020 3
2021 1
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Steenbruggen TG, Wolf DM, Campbell MJ, Sanders J, Cornelissen S, Thijssen B, Salgado RA, Yau C, O-Grady N, Basu A, Bhaskaran R, Mittempergher L, Hirst GL, Coppe JP, Kok M, Sonke GS, van 't Veer LJ, Horlings HM. Steenbruggen TG, et al. Among authors: mittempergher l. Breast Cancer Res. 2023 Oct 4;25(1):117. doi: 10.1186/s13058-023-01717-1. Breast Cancer Res. 2023. PMID: 37794508 Free PMC article.
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test.
Mittempergher L, Delahaye LJ, Witteveen AT, Snel MH, Mee S, Chan BY, Dreezen C, Besseling N, Luiten EJ; Annuska M Glas. Electronic address: Annuska.Glas@agendia.com. Mittempergher L, et al. Transl Oncol. 2020 Apr;13(4):100756. doi: 10.1016/j.tranon.2020.100756. Epub 2020 Mar 21. Transl Oncol. 2020. PMID: 32208353 Free PMC article.
Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.
Correia L, Magno R, Xavier JM, de Almeida BP, Duarte I, Esteves F, Ghezzo M, Eldridge M, Sun C, Bosma A, Mittempergher L, Marreiros A, Bernards R, Caldas C, Chin SF, Maia AT. Correia L, et al. Among authors: mittempergher l. NPJ Breast Cancer. 2022 Jun 8;8(1):71. doi: 10.1038/s41523-022-00435-9. NPJ Breast Cancer. 2022. PMID: 35676284 Free PMC article.
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
Mittempergher L, Delahaye LJMJ, Witteveen AT, Spangler JB, Hassenmahomed F, Mee S, Mahmoudi S, Chen J, Bao S, Snel MHJ, Leidelmeijer S, Besseling N, Bergstrom Lucas A, Pabón-Peña C, Linn SC, Dreezen C, Wehkamp D, Chan BY, Bernards R, van 't Veer LJ, Glas AM. Mittempergher L, et al. J Mol Diagn. 2019 Sep;21(5):808-823. doi: 10.1016/j.jmoldx.2019.04.007. Epub 2019 Jun 4. J Mol Diagn. 2019. PMID: 31173928 Free article.
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.
Kuilman MM, Ellappalayam A, Barcaru A, Haan JC, Bhaskaran R, Wehkamp D, Menicucci AR, Audeh WM, Mittempergher L, Glas AM. Kuilman MM, et al. Among authors: mittempergher l. Breast Cancer Res Treat. 2022 Oct;195(3):263-274. doi: 10.1007/s10549-022-06698-x. Epub 2022 Aug 19. Breast Cancer Res Treat. 2022. PMID: 35984580 Free PMC article.
Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions.
Göker E, Hendriks MP, van Tilburg M, Barcaru A, Mittempergher L, van Egmond A, Kleijn M, Generali D; of the NBREaST II Investigators Group. Göker E, et al. Among authors: mittempergher l. Eur J Cancer. 2022 May;167:92-102. doi: 10.1016/j.ejca.2022.03.003. Epub 2022 Apr 11. Eur J Cancer. 2022. PMID: 35421703 Free article.
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.
Mittempergher L, Piskorz AM, Bosma AJ, Michaut M, Wisman GBA, Kluin RJC, Nieuwland M, Brugman W, van der Ven KJW, Marass F, Morris J, Rosenfeld N, Jimenez-Linan M, de Jong S, van der Zee AGJ, Brenton JD, Bernards R. Mittempergher L, et al. PLoS One. 2020 Jul 8;15(7):e0235766. doi: 10.1371/journal.pone.0235766. eCollection 2020. PLoS One. 2020. PMID: 32639993 Free PMC article.
25 results